E. coli asparaginase

DRUG2 trials

Sponsors

Dana-Farber Cancer Institute

Conditions

Acute Lymphoblastic Leukemia

Phase 2

ALL Adult Consortium Trial: Adult ALL Trial

CompletedNCT00476190

Dana-Farber Cancer InstituteAcute Lymphoblastic Leukemia

Start: 2007-04-30End: 2020-03-31Updated: 2025-06-12

Phase 3

Treatment of Acute Lymphoblastic Leukemia in Children

CompletedNCT00165178

Dana-Farber Cancer InstituteAcute Lymphoblastic Leukemia

Start: 2000-09-30End: 2011-05-31Updated: 2013-04-25